102 related articles for article (PubMed ID: 2268980)
1. Use of aminohydroxypropylidene bisphosphonate (AHPrBP, "APD") for the treatment of hypercalcemia in patients with renal impairment.
Yap AS; Hockings GI; Fleming SJ; Khafagi FA
Clin Nephrol; 1990 Nov; 34(5):225-9. PubMed ID: 2268980
[TBL] [Abstract][Full Text] [Related]
2. Safety of pamidronate in patients with renal failure and hypercalcemia.
Machado CE; Flombaum CD
Clin Nephrol; 1996 Mar; 45(3):175-9. PubMed ID: 8706358
[TBL] [Abstract][Full Text] [Related]
3. Comment on "Use of aminohydroxypropylidene bisphosphonate (AHPrBP, "APD") for the treatment of hypercalcemia in patients with renal impairment" by Yap et al.
Kwan JT; Cunningham J
Clin Nephrol; 1991 Apr; 35(4):182. PubMed ID: 1855321
[No Abstract] [Full Text] [Related]
4. Oral versus intravenous AHPrBP (APD) in the treatment of hypercalcemia of malignancy.
Thiébaud D; Portmann L; Jaeger P; Jacquet AF; Burckhardt P
Bone; 1986; 7(4):247-53. PubMed ID: 3768203
[TBL] [Abstract][Full Text] [Related]
5. Dose/response study of aminohydroxypropylidene bisphosphonate in tumor-associated hypercalcemia.
Body JJ; Pot M; Borkowski A; Sculier JP; Klastersky J
Am J Med; 1987 May; 82(5):957-63. PubMed ID: 3578365
[TBL] [Abstract][Full Text] [Related]
6. Effect of combination treatment with a vitamin D analog (OCT) and a bisphosphonate (AHPrBP) in a nude mouse model of cancer-associated hypercalcemia.
Endo K; Katsumata K; Iguchi H; Kubodera N; Teramoto T; Ikeda K; Fujita T; Ogata E
J Bone Miner Res; 1998 Sep; 13(9):1378-83. PubMed ID: 9738509
[TBL] [Abstract][Full Text] [Related]
7. Aminohydroxypropylidene bisphosphonate (AHPrBP) treatment of severe immobilization hypercalcaemia in a young patient.
Varache N; Audran M; Clochon P; Lortholary A; Bouachour G; Alquier P; Basle MF
Clin Rheumatol; 1991 Sep; 10(3):328-32. PubMed ID: 1790647
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic hypocalcaemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma.
Henley D; Kaye J; Walsh J; Cull G
Intern Med J; 2005 Dec; 35(12):726-8. PubMed ID: 16313549
[TBL] [Abstract][Full Text] [Related]
9. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
Stojimirović B; Grujić-Adanja G
Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
[TBL] [Abstract][Full Text] [Related]
10. Use of bisphosphonates for resistant hypercalcemia in children with acute lymphoblastic leukemia: report of two cases and review of the literature.
Andiran N; Alikaşifoğlu A; Küpeli S; Yetgin S
Turk J Pediatr; 2006; 48(3):248-52. PubMed ID: 17172070
[TBL] [Abstract][Full Text] [Related]
11. Posttraumatic parathyroid crisis and severe hypercalcemia treated with intravenous bisphosphonate (APD). Case report.
Canivet JL; Damas P; Lamy M
Acta Anaesthesiol Belg; 1990; 41(1):47-50. PubMed ID: 2360392
[TBL] [Abstract][Full Text] [Related]
12. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
[TBL] [Abstract][Full Text] [Related]
13. Dose-response in the treatment of hypercalcemia of malignancy by a single infusion of the bisphosphonate AHPrBP.
Thiébaud D; Jaeger P; Jacquet AF; Burckhardt P
J Clin Oncol; 1988 May; 6(5):762-8. PubMed ID: 3367184
[TBL] [Abstract][Full Text] [Related]
14. The use of pamidronate in three children with renal disease.
Sellers E; Sharma A; Rodd C
Pediatr Nephrol; 1998 Nov; 12(9):778-81. PubMed ID: 9874327
[TBL] [Abstract][Full Text] [Related]
15. Leukaemia-associated hypercalcaemia in a 10-year-old boy: effectiveness of aminohydroxypropylidene biphosphonate.
Boudailliez BR; Pautard BJ; Sebert JL; Kremp O; Piussan CX
Pediatr Nephrol; 1990 Sep; 4(5):510-1. PubMed ID: 2242318
[TBL] [Abstract][Full Text] [Related]
16. [Development of peritoneal dialysis at Rijeka Clinical Hospital Center].
Zivcić-Cosić S; Vlahović A; Grzetić M; Matić-Glazar D
Acta Med Croatica; 2004; 58(3):215-20. PubMed ID: 15503685
[TBL] [Abstract][Full Text] [Related]
17. Hypercalcemia and refractory peritonitis alert the condition of tuberculous peritonitis: a case report and review literature.
Treamtrakanpon W; Kanjanabuch T; Eiam-Ong S
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S148-52. PubMed ID: 22043583
[TBL] [Abstract][Full Text] [Related]
18. Intravenous pamidronate sodium therapy in immobilization-related hypercalcemia.
Tamion F; Bonmarchand F; Girault C; Chevron V; Leroy J
Clin Nephrol; 1995 Feb; 43(2):138-9. PubMed ID: 7736680
[No Abstract] [Full Text] [Related]
19. Fast and effective treatment of malignant hypercalcemia. Combination of suppositories of calcitonin and a single infusion of 3-amino 1-hydroxypropylidene-1-bisphosphonate.
Thiébaud D; Jacquet AF; Burckhardt P
Arch Intern Med; 1990 Oct; 150(10):2125-8. PubMed ID: 2222097
[TBL] [Abstract][Full Text] [Related]
20. [Neoplasmic acute hypercalcemia with kidney failure. Possibilities and limitations of treatment by extrarenal purification].
Raphael JC; Kleinknecht D; Chanard J; Jungers P
Presse Med (1893); 1971 May; 79(24):1103-6. PubMed ID: 5580537
[No Abstract] [Full Text] [Related]
[Next] [New Search]
